Renovorx, Inc. cash flow statement

In fiscal 2025, Renovorx, Inc.'s operations generated −$11.0m of cash; it spent $2,000 on capital projects, leaving free cash flow of −$11.0m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Renovorx, Inc.: cash flow statement, annual
Fiscal year	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash from operations	−9	−11	−12
Depreciation and amortisation	0	2	1
Stock-based pay	1	1	2
Capital spending	0	0	0
Free cash flow	−9	−11	−12
Free cash flow after stock pay	−10	−12	−13
Shares issued	17	12	—

US$ millions unless shown otherwise. Fiscal quarters.

Renovorx, Inc.: cash flow statement, quarterly
Quarter	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Cash from operations	−3	−2	−2	−3	−4	−3
Depreciation and amortisation	0	1	1	0	0	0
Stock-based pay	0	0	0	0	0	1
Capital spending	0	0	0	0	0	0
Free cash flow	−3	−2	−2	−3	−4	−3
Free cash flow after stock pay	−4	−3	−3	−3	−4	−4
Shares issued	12	0	0	—	10	0

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ICU vs RNXT FEMY vs RNXT IMDX vs RNXT

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Renovorx, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Renovorx, Inc.